Medical Insurance for basic services at SCMCC

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of a n...

February 21, 2019 | Thursday | News
YITU Healthcare publishes major AI breakthrough

YITU Healthcare has successfully used natural language processing (NLP) to achieve high accuracy rates on par with docto...

February 20, 2019 | Wednesday | News
WuXi STA signs exclusive technology and marketing partnership with BioLingus

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus, a Swiss biotech company,...

February 19, 2019 | Tuesday | News
EMA completes inspection of cGMP DS and DP facilities at WuXi Biologics

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

February 19, 2019 | Tuesday | News
Chipscreen Biosciences unites with Innovent for colorectal cancer therapy

Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel s...

February 18, 2019 | Monday | News
Cigna brings Medical Plan on OneDegree Global's Online Platform

Cigna Corporation's Hong Kong business has announced that its Cigna Plus Medical Plan health insurance pr...

February 18, 2019 | Monday | News
Burning Rock completes Series C financing of RMB 850M

Burning Rock recently held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 mil...

February 15, 2019 | Friday | News
Innovent announces first patient dosing of IBI 101 study

Innovent Biologics, Inc. (Innovent) , a world-class biopharmaceutical company that develops, manufactures and commercial...

February 15, 2019 | Friday | News
Ascletis, 3-V Biosciences ink strategic license agreement for NASH drug

Ascletis Pharma through its subsidiary, and 3-V Biosciences have entered into an exclusive license agreement for 3-V Bio...

February 14, 2019 | Thursday | News
3SBio and Verseau team up for Immuno-Oncology Therapies

3SBio and Verseau Therapeutics have announced a partnership agreement focused on the development and commercialization o...

February 13, 2019 | Wednesday | News
WuXi Biologics enters into commercial manufacturing partnership with Amicus

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

February 13, 2019 | Wednesday | News
Samsung Bioepis, C-Bridge Capital to develop next-gen biosimilars

Samsung Bioepis Co., Ltd. has announced its expansion in mainland China through a licensing agreement with C-Bridge Capi...

February 12, 2019 | Tuesday | News
Female contraceptive market set to be worth $8.7bn by 2027

Contraceptive market sales were estimated to be $6.3bn across the 8MM (US, France, Germany, Italy, Spain, UK, Japan...

February 11, 2019 | Monday | News
Lunar New Year focuses on traditional chinese medicine for cancer treatment

The Lunar New Year welcomes a focus on the wellbeing of the entire body leading to renewed discussions about the benefit...

February 9, 2019 | Saturday | Opinion
CStone, IMPACT Therapeutics’ anti-tumor therapy gets IND filing acceptance

CStone Pharmaceutical and IMPACT Therapeutics, Inc. have jointly announced that an Investigational New Drug (IND) filing...

February 8, 2019 | Friday | News
Invitrocue signs technology development agreement with SIBCB

Invitrocue, a leading healthcare bio-analytic solutions provider, has announced the signing of a new technology developm...

February 8, 2019 | Friday | News
Glenmark Pharma signs an agreement with Grandpharma

Glenmark Pharmaceuticals Ltd. (Glenmark) has announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered i...

February 7, 2019 | Thursday | News
EdiGene raises $10M in Series pre-B

EdiGene Inc., headquartered in Beijing, with operational subsidiaries in Guangzhou, China and Cambridge, USA and which d...

February 6, 2019 | Wednesday | News